TARA
Protara Therapeutics Inc

5,459
Mkt Cap
$365.55M
Volume
530,274.00
52W High
$7.82
52W Low
$2.77
PE Ratio
-4.91
TARA Fundamentals
Price
$7.04
Prev Close
$7.08
Open
$7.06
50D MA
$5.98
Beta
1.28
Avg. Volume
1.08M
EPS (Annual)
-$2.17
P/B
2.07
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Protara Therapeutics, Inc. (NASDAQ:TARA) Receives Average Recommendation of "Moderate Buy" from Analysts
Protara Therapeutics, Inc. (NASDAQ:TARA - Get Free Report) has been given an average rating of "Moderate Buy" by the seven research firms that are covering the company, MarketBeat Ratings reports...
MarketBeat·18d ago
News Placeholder
More News
News Placeholder
Assenagon Asset Management S.A. Invests $1.34 Million in Protara Therapeutics, Inc. $TARA
Assenagon Asset Management S.A. acquired a new position in shares of Protara Therapeutics, Inc. (NASDAQ:TARA - Free Report) in the third quarter, according to its most recent disclosure with the...
MarketBeat·1mo ago
News Placeholder
Protara Therapeutics, Inc. (NASDAQ:TARA) Receives Average Rating of "Moderate Buy" from Brokerages
Protara Therapeutics, Inc. (NASDAQ:TARA - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the six ratings firms that are presently covering the company, Marketbeat...
MarketBeat·1mo ago
News Placeholder
Acorn Capital Advisors LLC Acquires 472,315 Shares of Protara Therapeutics, Inc. $TARA
Acorn Capital Advisors LLC increased its stake in shares of Protara Therapeutics, Inc. (NASDAQ:TARA - Free Report) by 36.9% during the second quarter, according to its most recent Form 13F filing...
MarketBeat·2mo ago
News Placeholder
Protara Therapeutics, Inc. $TARA is Velan Capital Investment Management LP's 4th Largest Position
Velan Capital Investment Management LP increased its stake in Protara Therapeutics, Inc. (NASDAQ:TARA - Free Report) by 28.3% during the 2nd quarter, according to its most recent disclosure with the...
MarketBeat·2mo ago
News Placeholder
Protara Therapeutics Shares Sink 16% After $75 Mln Public Offering
(RTTNews) - Shares of Protara Therapeutics Inc. (TARA) dropped about 16% in pre-market trading on Friday after the company announced the pricing of its underwritten public offering of about 13.04...
Nasdaq News: Markets·2mo ago
News Placeholder
Protara Therapeutics (NASDAQ:TARA) Receives "Buy" Rating from HC Wainwright
HC Wainwright reissued a "buy" rating and set a $23.00 target price on shares of Protara Therapeutics in a research report on Wednesday...
MarketBeat·2mo ago
News Placeholder
Protara Therapeutics, Inc. (NASDAQ:TARA) Given Average Rating of "Moderate Buy" by Analysts
Shares of Protara Therapeutics, Inc. (NASDAQ:TARA - Get Free Report) have received an average recommendation of "Moderate Buy" from the seven analysts that are presently covering the firm, MarketBeat...
MarketBeat·2mo ago
News Placeholder
HC Wainwright Reaffirms "Buy" Rating for Protara Therapeutics (NASDAQ:TARA)
HC Wainwright reiterated a "buy" rating and set a $23.00 price objective on shares of Protara Therapeutics in a research note on Wednesday...
MarketBeat·2mo ago
News Placeholder
What's Going On With Protara Therapeutics Stock Wednesday?
TARA-002, a cell-based therapy by Protara Therapeutics, shows promising results in treating lymphatic malformations in pediatric patients.read more...
Benzinga·3mo ago
<
1
2
...
>

Latest TARA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.